Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the management of obesity. This medication works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://lawsonhyxy832939.blogzag.com/82339536/semaglutide-a-potential-solution-for-obesity